Basic studies on a labeled anti-mucin antibody detectable by infrared-fluorescence endoscopy

Background. We developed a fluorescent dye, indocyanine green (ICG)-sulfo-OSu, which was excited by infrared rays and conjugated to various antibodies. We attempted to clarify the staining patterns of anti-sulfomucin and anti-MUC1 antibodies in gastrointestinal cancer. We then evaluated the potential of the dye as a fluorescent label for antibodies specific to cancer, to be used as a diagnostic method for microcancer, with infrared fluorescence endoscopy. Methods. Paraffin sections of samples collected from 10 patients with esophageal cancer, 30 patients with gastric cancer, and 20 patients with colorectal cancer were immunohistologically stained using an anti-sulfomucin antibody and an anti-MUC1 antibody, and the staining patterns were examined. If a section had a high staining intensity, it was reacted with the ICG-suflo-OSu-labeled antibody and evaluated with infrared fluorescence imaging. Results. The staining patterns with the antibodies varied depending on the organs and the histological types and depth of the cancers, but the staining was generally good and the staining on the mucosal surface of cancer tissues was retained. Good images of cancer cells could be obtained by infrared fluorescence observation using the ICG-sulfo-OSu-labeled anti-MUC1 antibody. Conclusions. The anti-MUC1 antibody stained gastrointestinal cancer cells well, and nearly specific infrared fluorescence in cancer tissues was observed using the labeled anti-MUC1 antibody. The ICG-sulfo-OSu-labeled anti-MUC1 antibody has possible usefulness for the screening of cancer via infrared fluorescence endoscopy.

[1]  A. Daver,et al.  Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content. , 1986, Anticancer research.

[2]  S. Curley,et al.  Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE‐025 and IMMU‐4 monoclonal antibodies and proposed directions for clinical trials , 1993, Cancer.

[3]  D. Ota,et al.  Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases. , 1989, Cancer research.

[4]  R. Davies.  Ultraviolet Radiation Damage in DNA , 1995 .

[5]  S. Ito,et al.  Antibodies labeled with fluorescence-agent excitable by infrared rays , 1998, Journal of Gastroenterology.

[6]  T. Irimura,et al.  Expression of Sulfated Carbohydrate Chains Detected by Monoclonal Antibody 91.9H in Human Gastric Cancer Tissues , 1994, Japanese journal of cancer research : Gann.

[7]  Y. S. Kim.  Mucin glycoproteins in gastrointestinal malignancies and metastasis : Mucus glycoproteins in the gastrointestinal tract , 1993 .

[8]  D. Ota,et al.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. , 1994, Gastroenterology.

[9]  T. Irimura,et al.  Expression of Mucin‐associated Sulfo‐Lea Carbohydrate Epitopes on Human Colon Carcinoma Cells , 1998, Japanese journal of cancer research : Gann.

[10]  T. Irimura,et al.  Reciprocal control of colon-specific sulfomucin and sialosyl-Tn antigen expression in human colorectal neoplasia , 1997, Virchows Archiv.

[11]  N. Muguruma,et al.  Reflected Illumination‐Type Imaging System for the Development of Infrared Fluorescence Endoscopy , 1999 .

[12]  H. Egami,et al.  Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma. , 1999, International journal of oncology.

[13]  T. Irimura,et al.  A Novel Monoclonal Antibody Specific for Sialylated MUC1 Mucin , 1996, Japanese journal of cancer research : Gann.

[14]  S. Okamura,et al.  Labeled carcinoembryonic antigen antibodies excitable by infrared rays: a novel diagnostic method for micro cancers in the digestive tract. , 1999, Internal medicine.

[15]  Scott L. Sutter,et al.  Synthesis, Chromatographic Separation, and Characterization of Near-Infrared Labeled DNA Oligomers for Use in DNA Sequencing , 1995 .

[16]  H. Honda,et al.  Visualization of human gastric ancer with a novel indrared furescent labeling marker of anti‐carcinoembryonic antigen in vitro , 2000 .

[17]  F. Fazio,et al.  Monoclonal antibody pretargetting techniques for tumour localization: the avidin‐biotin system , 1991, Nuclear medicine communications.

[18]  S. Yonezawa,et al.  Expression of mucin antigens in human cancers and its relationship with malignancy potential , 1997, Pathology international.

[19]  R. Herwig,et al.  Immunoscopy--a technique combining endoscopy and immunofluorescence for diagnosis of colorectal carcinoma. , 1998, Gastrointestinal endoscopy.

[20]  T. Irimura,et al.  Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  H. Iishi,et al.  Diagnosis of gastric cancers with fluorescein‐labeled monoclonal antibodies to carcinoembryonic antigen , 1989, Lasers in surgery and medicine.

[22]  S. Okamura,et al.  Development of agents for reinforcement of fluorescence on near-infrared ray excitation for immunohistological staining. , 1998, Bioorganic & medicinal chemistry.

[23]  H. Honda,et al.  Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro. , 2001, Endoscopy.

[24]  T. Irimura,et al.  Vital immunostaining of human gastric and colorectal cancers grafted into nude mice: a preclinical assessment of a potential adjunct to videoendoscopy , 2000, Journal of Gastroenterology.

[25]  D. Ota,et al.  Human colonic sulfomucin identified by a specific monoclonal antibody. , 1991, Cancer research.

[26]  S. Ito,et al.  Development of fluorescence-emitting antibody labeling substance by near-infrared ray excitation , 1995 .

[27]  相良 光久.  Expression of mucin 1(MUC1)in esophageal squamous-cell carcinoma : Its relationship with prognosis , 2001 .

[28]  T. Irimura,et al.  Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma , 1998, Journal of Gastroenterology.

[29]  S. Natsugoe,et al.  Expression of mucin 1 (MUC1) in esophageal squamous‐cell carcinoma: Its relationship with prognosis , 1999, International journal of cancer.

[30]  S. Ito,et al.  Synthesis and reactivities of 3-indocyanine-green-acyl-1,3-thiazolidine-2-thione (ICG-ATT) as a new near-infrared fluorescent-labeling reagent. , 1998, Bioorganic & medicinal chemistry.